DUXAP8 and hepatocellular carcinoma: Diagnostic and prognostic analysis indicated that DUXAP8, MEGEA1, MKRN3, and DGKI can be used to diagnosis HCC, while DUXAP8 and RNF2 can be used to predict the prognosis of HCC.